Focus:
We profiled MCWEF in latter part of 2014...stock ran from .70s to near 1 following....Recall producing oil at half the cost of the majors....Re-examine back at .58
Outside
NBT profiling ORGS regarding news yesterday: RE: grant they received to assist funding for their diabetes cure..Their breakthrough approach eliminates the need for insulin shots..Last fall the stock ran from .40 to a buck on similiar news...Now that is back @ ongoing support levels in .40s, technicals have become quite appealing. ..curing diabetes by reprogramming liver cells..worth a look
http://bit.ly/1Bs5gyp
Initiating Coverage on Orgenesis, Inc. (ORGS) with $2.50 12-18 Month Target: Broad ORGS Patent for Turning Liver Cells into Insulin Producing Cells Creates a Potential Cure for Diabetes
SMRS being touted
Notable earnings before today's open: AAL, ABMD, AKS, AMG, AOS, AUDC, AVX, BMY, BTU, CAT, CIT, COH, DD, DHR, DOV, ERIC, FCFS, FCX, FMER, GLW, IIVI, ISSI, ITW, LMT, LXK, MMM, NEE, NUE, NVS, OSK, PFE, PG, PH, PHG, PII, PLD, SNV, TDG, WAT
Notable earnings after today's close: AAPL, ACE, AMCC, AMGN, ARAY, BXP, CLMS, CNI, CNMD, CYT, DOX, EA, ETH, EZPW, FSL, FTK, ILMN, JNPR, MRCY, OTEX, POL, SYK, T, TSS, VMW, WDC, X, YHOO
No comments:
Post a Comment